What's in Mayne Pharma International Pty Ltd's pipeline?

Mayne Pharma International Pty Ltd has 6 drugs in our index: 5 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Mayne Pharma International Pty Ltd's portfolio?

Top competitors by shared drug class: Galderma R&D, LEO Pharma, Ruhr University of Bochum, Stiefel, a GSK Company, Sun Pharmaceutical Industries Limited.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/mayne-pharma-international-pty-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Mayne Pharma International Pty Ltd — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mayne Pharma International Pty Ltd pipeline: 5 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

5 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Sporanox	Sporanox	marketed			Other
Lozanoc	Lozanoc	marketed			Other
Elimite	Elimite	marketed			Other
Permethrin Cream, 5%	Permethrin Cream, 5%	marketed	Synthetic pyrethroid insecticide	Voltage-gated sodium channels (arthropod nervous system)	Dermatology / Parasitology
Halobetasol Topical Foam	Halobetasol Topical Foam	marketed	Topical corticosteroid (Class I, super-potent)	Glucocorticoid receptor	Dermatology
Placebo 0% Lotion	Placebo 0% Lotion	phase 3

Therapeutic area mix

Other · 3
Dermatology · 1
Dermatology / Parasitology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Galderma R&D · 1 shared drug class
LEO Pharma · 1 shared drug class
Ruhr University of Bochum · 1 shared drug class
Stiefel, a GSK Company · 1 shared drug class
Sun Pharmaceutical Industries Limited · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Mayne Pharma International Pty Ltd:

Cite this brief

Drug Landscape (2026). Mayne Pharma International Pty Ltd — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/mayne-pharma-international-pty-ltd. Accessed 2026-05-17.